[Federal Register Volume 80, Number 66 (Tuesday, April 7, 2015)]
[Notices]
[Pages 18654-18655]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-07993]


-----------------------------------------------------------------------

NUCLEAR REGULATORY COMMISSION


Advisory Committee on the Medical Uses of Isotopes; Call for 
Nominations

AGENCY: U.S. Nuclear Regulatory Commission.

ACTION: Call for Nominations.

-----------------------------------------------------------------------

SUMMARY: The U.S. Nuclear Regulatory Commission (NRC) is advertising 
for nominations for the position of Nuclear Pharmacist on the Advisory 
Committee on the Medical Uses of Isotopes (ACMUI). Nominees should be a 
currently practicing nuclear pharmacist.

[[Page 18655]]


DATES: Nominations are due on or before June 8, 2015.

NOMINATION PROCESS: Submit an electronic copy of resume or curriculum 
vitae to Ms. Sophie Holiday, <a href="/cdn-cgi/l/email-protection#beedd1ced6d7db90f6d1d2d7dadfc7fed0ccdd90d9d1c8"><span class="__cf_email__" data-cfemail="fba8948b93929ed5b39497929f9a82bb958998d59c948d">[email protected]</span></a>. Please ensure that 
the resume or curriculum vitae includes the following information, if 
applicable: Education; certification; professional association 
membership and committee membership activities; duties and 
responsibilities in current and previous clinical, research, and/or 
academic position(s).

FOR FURTHER INFORMATION CONTACT: Ms. Sophie Holiday, U.S. Nuclear 
Regulatory Commission, Office of Nuclear Material Safety and 
Safeguards; telephone (404) 997-4691; email: <a href="/cdn-cgi/l/email-protection#beedd1ced6d7db90f6d1d2d7dadfc7fed0ccdd90d9d1c8"><span class="__cf_email__" data-cfemail="8bd8e4fbe3e2eea5c3e4e7e2efeaf2cbe5f9e8a5ece4fd">[email protected]</span></a>.

SUPPLEMENTARY INFORMATION: The ACMUI Nuclear Pharmacist provides advice 
on issues associated with the regulation of nuclear pharmacy 
applications of byproduct material. This advice includes providing 
input on NRC proposed rules and guidance, providing recommendations on 
the training and experience requirements for Authorized Nuclear 
Pharmacists, identifying medical events associated with these uses, 
evaluating non-routine uses of byproduct material, bringing key issues 
in the nuclear pharmacy community to the attention of NRC staff, as 
they relate to radiopharmaceuticals, radiation safety and NRC medical-
use policy.
    ACMUI members are selected based on their educational background, 
certification(s), work experience, involvement and/or leadership in 
professional society activities, and other information obtained in 
letters or during the selection process.
    ACMUI members possess the medical and technical skills needed to 
address evolving issues. The current membership is comprised of the 
following professionals: (a) Nuclear medicine physician; (b) nuclear 
cardiologist; (c) two radiation oncologists; (d) diagnostic 
radiologist; (e) therapy medical physicist; (f) nuclear medicine 
physicist; (g) nuclear pharmacist; (h) health care administrator; (i) 
radiation safety officer; (j) patients' rights advocate; (k) Food and 
Drug Administration representative; and (l) Agreement State 
representative.
    NRC is inviting nominations for the Nuclear Pharmacist to the 
ACMUI. The term of the individual currently occupying this position 
will end March 29, 2016. Committee members currently serve a four-year 
term and may be considered for reappointment to an additional term.
    Nominees must be U.S. citizens and be able to devote approximately 
160 hours per year to Committee business. Members who are not Federal 
employees are compensated for their service. In addition, members are 
reimbursed for travel (including per-diem in lieu of subsistence) and 
are reimbursed secretarial and correspondence expenses. Full-time 
Federal employees are reimbursed travel expenses only.
    Security Background Check: The selected nominee will undergo a 
thorough security background check. Security paperwork may take the 
nominee several weeks to complete. Nominees will also be required to 
complete a financial disclosure statement to avoid conflicts of 
interest.

    Dated at Rockville, Maryland, this 1st day of April, 2015.

    For the U.S. Nuclear Regulatory Commission.
Andrew L. Bates,
Advisory Committee Management Officer.
[FR Doc. 2015-07993 Filed 4-6-15; 8:45 am]
BILLING CODE CODE 7590-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>